Predictors for recombinant HIV infection in a thai cohort

Sexually Transmitted Diseases

Volumn 38, Issue 11, 2011, Pages 1046-1049

  Khawcharoenporn, Thana ^a   Apisarnthanarak, Anucha ^a   Gesprasert, Goragoch ^b   Jaiyen, Yanin ^b   Mundy, Linda M ^c   Thitithanyanont, Arunee ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Mahidol University   (Thailand)

^c LM Mundy LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; RECOMBINANT HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SEXUAL BEHAVIOR; THAILAND; VIRUS RECOMBINANT;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTITUTION; RECOMBINATION, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEXUAL PARTNERS; THAILAND;

EID: 80054112321     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31822c8d90     Document Type: Article

References (23)

1. Los Alamos National Laboratory, Department of Health and Human Services and National Institutes of Health. HIV Sequence Database. Available at: http://www.hiv.lahl.gov/content/sequence/HIV/mainpage.html. Accessed May 1, 2010.
2. Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: Current state of knowl-edge and potential clinical consequences. Clin Infect Dis 2002; 34:1108-1114. (Pubitemid 34289684)
3. Brodine SK, Starkey MJ, Shaffer RA, et al. Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort. AIDS 2003; 17:2521-2527. (Pubitemid 38393326)
4. Tatt ID, Barlow KL, Clewley JP, et al. Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997-2000. J Acquir Immun Defic Syndr 2004; 36:1092-1099. (Pubitemid 38989376)
5. Wichukchinda N, Shiino T, Srisawat J, et al. Heterosexual transmission of novel CRF01-AE and subtype B recombinant forms of HIV type 1 in northern Thailand. AIDS Res Hum Retroviruses 2005; 21:734-738.
6. Tovanabutra S, Polonis V, De Souza M, et al. First CRF01-AE/B recombinant of HIV-1 is found in Thailand. AIDS 2001; 15: 1063-1065.
7. Tovanabutra S, Watanaveeradej V, Viputtikul K, et al. A new circulating recombinant form, CRF15-01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res Hum Retroviruses 2003; 19:561-567.
8. Tovanabutra S, Beyrer C, Sakkhachornphop S, et al. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res Hum Retroviruses 2004; 20:465-475. (Pubitemid 38720959)
9. Watanaveeradej V, Benenson MW, Souza MD, et al. Molecular epidemiology of HIV Type 1 in preparation for a Phase III primeboost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping. AIDS Res Hum Retroviruses 2006; 22:801-807. (Pubitemid 44735008)
10. Kijak GH, Beyrer C, Tovanabutra S, et al. Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: Associations of risk with genetic complexity. Drug Alcohol Depend 2011; 116:24-30.
11. Apisarnthanarak A, Jirayasethpong T, Sa-nguansilp C, et al. Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand. HIV Med 2008; 9:322-325. (Pubitemid 351522665)
12. van der Kuyl AC, Kozaczynska K, Ariën KK, et al. Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness. Retrovirology 2010; 7:60.
13. Carr JK, Torimiro JN, Wolfe ND, et al. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001; 286:168-181. (Pubitemid 32675477)
14. Khawcharoenporn T, Apisarnthanarak A, Kitkungvan D, et al. Feasibility of primary HIV care in a Thai tertiary care centre. Int J STD AIDS 2009; 20:669-670.
15. Sungkanuparph S, Anekthananon T, Hiransuthikul N, et al. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the Thai AIDS Society (TAS) 2008. J Med Assoc Thai 2008; 91:1925-1935.
16. Robertson DL, Sharp PM, McCutchan FE, et al. Recombination in HIV-1. Nature 1995; 374:124-126.
17. Land AM, Luo M, Pilon R, et al. High prevalence of genetically similar HIV-1 recombinants among infected sex workers in Nairobi, Kenya. AIDS Res Hum Retroviruses 2008; 24:1455-1460.
18. Arroyo MA, Sateren WB, Serwadda D, et al. Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda. J Acquir Immun Defic Syndr 2006; 43:440-445. (Pubitemid 44737102)
19. Arroyo MA, Hoelscher M, Sateren W, et al. HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 2005; 19:1517-1524. (Pubitemid 41400698)
20. Lospitao E, Alvarez A, Soriano V, et al. HIV-1 subtypes in Spain: A retrospective analysis from 1995 to 2003. HIV Med 2005; 6:313-320. (Pubitemid 41335139)
21. Bocket L, Cheret A, Deuffic-Burban S, et al. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. Antivir Ther 2005; 10:247-254. (Pubitemid 41151031)
22. Alexander CS, Montessori V, Wynhoven B, et al. Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia. Antivir Ther 2002; 7:31-35. (Pubitemid 36285549)
23. Laurent C, Bourgeois A, Faye MA, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02-AG strain and patients not infected with CRF02+AG, in Western and West-Central Africa: A four-year prospective multicenter study. J Infect Dis 2002; 186:486-492. (Pubitemid 34876257)